» Articles » PMID: 21059894

Macroautophagy Regulates Energy Metabolism During Effector T Cell Activation

Overview
Journal J Immunol
Date 2010 Nov 10
PMID 21059894
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Macroautophagy is a highly conserved mechanism of lysosomal-mediated protein degradation that plays a key role in maintaining cellular homeostasis by recycling amino acids, reducing the amount of damaged proteins, and regulating protein levels in response to extracellular signals. We have found that macroautophagy is induced after effector T cell activation. Engagement of the TCR and CD28 results in enhanced microtubule-associated protein 1 light chain 3 (LC3) processing, increased numbers of LC3-containing vesicles, and increased LC3 flux, indicating active autophagosome formation and clearance. The autophagosomes formed in stimulated T cells actively fuse with lysosomes to degrade their cargo. Using a conditional KO mouse model where Atg7, a critical gene for macroautophagy, is specifically deleted in T cells, we have found that macroautophagy-deficient effector Th cells have defective IL-2 and IFN-γ production and reduced proliferation after stimulation, with no significant increase in apoptosis. We have found that ATP generation is decreased when autophagy is blocked, and defects in activation-induced cytokine production are restored when an exogenous energy source is added to macroautophagy-deficient T cells. Furthermore, we present evidence showing that the nature of the cargo inside autophagic vesicles found in resting T cells differs from the cargo of autophagosomes in activated T cells, where mitochondria and other organelles are selectively excluded. These results suggest that macroautophagy is an actively regulated process in T cells that can be induced in response to TCR engagement to accommodate the bioenergetic requirements of activated T cells.

Citing Articles

Autophagy repression by antigen and cytokines shapes mitochondrial, migration and effector machinery in CD8 T cells.

Sinclair L, Youdale T, Spinelli L, Gakovic M, Langlands A, Pathak S Nat Immunol. 2025; 26(3):429-443.

PMID: 40016525 PMC: 11876071. DOI: 10.1038/s41590-025-02090-1.


Targeting chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapeutic potential.

Wu J, Xu W, Su Y, Wang G, Ma J Acta Pharmacol Sin. 2024; .

PMID: 39548290 DOI: 10.1038/s41401-024-01416-3.


IFN-γ induces acute graft-versus-host disease by promoting HMGB1-mediated nuclear-to-cytoplasm translocation and autophagic degradation of p53.

Wang S, Cheng T, Chen X, Zeng C, Qin W, Xu Y Clin Sci (Lond). 2024; 138(20):1287-1304.

PMID: 39312196 PMC: 11479981. DOI: 10.1042/CS20241144.


Research progress of T cell autophagy in autoimmune diseases.

Zhao X, Ma D, Yang B, Wang Y, Zhang L Front Immunol. 2024; 15:1425443.

PMID: 39104538 PMC: 11298352. DOI: 10.3389/fimmu.2024.1425443.


STAT3 inhibition recovers regeneration of aged muscles by restoring autophagy in muscle stem cells.

Catarinella G, Bracaglia A, Skafida E, Procopio P, Ruggieri V, Parisi C Life Sci Alliance. 2024; 7(8).

PMID: 38843935 PMC: 11157169. DOI: 10.26508/lsa.202302503.


References
1.
He C, Klionsky D . Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009; 43:67-93. PMC: 2831538. DOI: 10.1146/annurev-genet-102808-114910. View

2.
Dure M, Macian F . IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. Mol Immunol. 2008; 46(5):999-1006. PMC: 2667138. DOI: 10.1016/j.molimm.2008.09.029. View

3.
Yu L, Strandberg L, Lenardo M . The selectivity of autophagy and its role in cell death and survival. Autophagy. 2008; 4(5):567-73. DOI: 10.4161/auto.5902. View

4.
Schwartz R . T cell anergy. Annu Rev Immunol. 2002; 21:305-34. DOI: 10.1146/annurev.immunol.21.120601.141110. View

5.
Klionsky D, Cuervo A, Seglen P . Methods for monitoring autophagy from yeast to human. Autophagy. 2007; 3(3):181-206. DOI: 10.4161/auto.3678. View